1809. The Future of US HIV Care in an Era of Generic Antiretrovirals
Session: Symposium: Healthcare Reform and the Future of HIV Care
Saturday, October 5, 2013: 3:00 PM
Room: The Moscone Center: 134 (Hall E)
John G. Bartlett, MD, FIDSA, Johns Hopkins University School of Medicine, Baltimore, MD

John G. Bartlett, M.D., received his undergraduate degree from Dartmouth University in 1959 and earned his medical degree at Upstate Medical Center in Syracuse, New York in 1963. He then completed residency training in Internal Medicine at the Brigham Hospital in Boston and the University of Alabama, Birmingham. Dr. Bartlett also completed fellowship training in Infectious Diseases at UCLA and at the Wadsworth Veterans Administration Hospital. In 1970, he joined the faculty at UCLA. He later moved to the faculty of Tufts University School of Medicine in Boston, where he served as associate chief of staff for research at the Boston VA Hospital. In 1980 he moved to Baltimore as Professor of Medicine and Chief of the Division of Infectious Diseases at Johns Hopkins University School of Medicine. Dr. Bartlett is an internationally renowned authority on AIDS and other infectious diseases. For 27 years, he has been a leader for the School of Medicine’s worldwide efforts to understand, prevent and treat AIDS. He received the prestigious 2005 Maxwell Finland Award for scientific achievement from the National Foundation for Infectious Diseases. Dr. Bartlett was the first to direct clinical trials in Baltimore of new treatments that prevent HIV from replicating, and he pioneered the development of dedicated inpatient and outpatient medical care for HIV-infected patients. In 1984, when AIDS was still in its infancy, he helped start a small clinic within the Moore Clinic to serve a small group of gay men with AIDS, which along with providing research data about how the disease spread, grew to become the centerpiece of the Johns Hopkins AIDS Service, and is the largest program for HIV care in Maryland. Bartlett co-chaired the national committee that drafted the first and all subsequent treatment guidelines for HIV-infected patients. He counsels numerous medical societies and health ministries around the world on infectious diseases in general and on AIDS specifically. Bartlett’s research interests have dealt with anaerobic infections, pathogenic mechanisms of Bacteroides fragilis, anaerobic pulmonary infections, and Clostridium difficile-associated colitis. Since joining Hopkins in 1980, his major interests have been HIV/AIDS, managed care of patients with HIV infection, Pneumonia (community acquired) and, most recently, bioterrorism. Clinically his interests include HIV primary care, General Infectious Diseases, HIV and Hemophilia, and HIV Managed Care. The 18th edition of his book Medical Management of HIV Infection will be published in March and has become the standard for HIV/AIDS healthcare providers throughout the world.



<< Previous Presentation | Next Presentation

Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 2nd with the exception of research findings presented at the IDWeek press conferences.